SEC Filings



PURE Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing our proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent that is manufactured as a liquid and delivered in various concentrations. We currently manufacture and distribute SDC-based disinfecting and sanitizing products, which are registered by the United States Environmental Protection Agency (EPA), the United States Food and Drug Administration (FDA) and Health Canada. We also manufacture and sell SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. We believe our technology platform has potential application in a number of industries and we intend to focus our current resources on providing food safety solutions to the food industry.

Corporate Governance

Code of Business Conduct and Ethics

Corporate Governance Guidelines

Audit Committee Charter

Compensation Committee Charter

Inquiries about stock accounts, or change in name or address may be directed to PURE Bioscience's stock transfer agent:

Other investor inquires may be directed to:

  • Mark Elliott
  • VP of Finance PURE Bioscience, Inc.

(619) 596-8600

Receive Report Materials Electronically

Shareholders may opt for the convenience of electronic shareholder materials. Subscribers receive messages containing links to the online annual report and proxy statement, and may vote their proxies online. Interested shareholders may sign up here.